1. Home
  2. VLOS vs ALEC Comparison

VLOS vs ALEC Comparison

Compare VLOS & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VLOS

Velos Acquisition I Corp. Class A Ordinary shares

N/A

Current Price

$10.70

Market Cap

251.5M

Sector

N/A

ML Signal

N/A

Logo Alector Inc.

ALEC

Alector Inc.

N/A

Current Price

$2.34

Market Cap

275.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VLOS
ALEC
Founded
2024
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
251.5M
275.8M
IPO Year
2024
2019

Fundamental Metrics

Financial Performance
Metric
VLOS
ALEC
Price
$10.70
$2.34
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
★ $4.42
AVG Volume (30 Days)
13.5K
★ 1.8M
Earning Date
08-13-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.70
Revenue
N/A
★ $21,045,000.00
Revenue This Year
N/A
$990.25
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$3.30
Revenue Growth
★ N/A
N/A
52 Week Low
$10.35
$1.09
52 Week High
$10.90
$2.84

Technical Indicators

Market Signals
Indicator
VLOS
ALEC
Relative Strength Index (RSI) 47.74 51.94
Support Level $10.67 $1.90
Resistance Level $10.75 $2.67
Average True Range (ATR) 0.08 0.23
MACD 0.00 -0.01
Stochastic Oscillator 63.64 37.20

Price Performance

Historical Comparison
VLOS
ALEC

About VLOS Velos Acquisition I Corp. Class A Ordinary shares

Velos Acquisition I Corp, formerly M3-Brigade Acquisition V Corp, is a blank check company.

About ALEC Alector Inc.

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

Share on Social Networks: